A family office based in the USA is looking to invest in technologies related to ophthalmology and oncology that are in the pre-clinical to PhI stages, and will generally invest $5-10M in series A rounds. The firm is willing to invest globally, with a special interest in companies based in North America, Europe and China.
The firm is interested in therapeutics, medical device and diagnostics companies with technologies in the ophthalmology and oncology spaces. The firm may consider digital health companies as well. For ophthalmology-related companies, the firm is most interested in small molecules or combination devices. For oncology-related companies, the firm prefers I/O technologies or diagnostics.
The firm prefers to take a board seat after investing.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Yes, I’m a co-investor in ophthalmology and preventing blindness mandates. Please let’s connect. Dan Conley c.908.917.3537